Domagoj, Markovic <br/><br/>
Effects of carvedilol therapy in patients with heart failure with preserved ejection fraction - Results from the Croatian heart failure (CRO-HF) registry.  [electronic resource] 

 -  Medicina clinica  01 2019 
 - 43-49 p.  digital 
<br/><br/> Publication Type: Clinical Study; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1578-8989 
<br/><br/><label>Standard No.: </label>10.1016/j.medcli.2018.02.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Aged<br/>Aged, 80 and over<br/>Carvedilol--therapeutic use<br/>Comorbidity<br/>Croatia--epidemiology<br/>Diabetes Mellitus--epidemiology<br/>Female<br/>Follow-Up Studies<br/>Heart Failure--blood<br/>Heart Ventricles--physiopathology<br/>Humans<br/>Hypertension--epidemiology<br/>Male<br/>Myocardial Infarction--epidemiology<br/>Prospective Studies<br/>Registries<br/>Severity of Illness Index<br/>Stroke Volume<br/>Survival Rate<br/>Treatment Outcome